Skip to main content
Veterinary Medicines

Interceptor Flavor 23 mg tablets for dogs

Not authorised
  • Milbemycin oxime

Product identification

Medicine name:
Interceptor Flavor 23 mg tablets for dogs
Interceptor Sabor 23 mg comprimidos para cães
Active substance:
  • Milbemycin oxime
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    23.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB01
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:
  • Cardboard box with 5 double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 6 tablets
  • Cardboard box with two double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 4 tablets
  • Cardboard box with double sided aluminium blister consisting of aluminium forming and lidding foils containing 6 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Europe Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Novartis Sante Animale
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 263/04/10DFVPT
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0124/004

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 3/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."